Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lion Bioscience acquires Trega in stock swap

Executive Summary

In a stock swap, Lion Bioscience will exchange its American depositary shares to acquire all Trega Biosciences (drug discovery technologies) outstanding shares, paying about $1.35 each--a (pr)38% premium to market average--or $35mm.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Stock
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies